According to a new report published by Allied Market Research, titled, “IV Catheters Market," The IV catheters market size was valued at $8.6 billion in 2022, and is estimated to reach $17.8 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032. An intravenous catheter is a catheter inserted into a vein to administer fluids or medications. IV catheters are essential tools for healthcare professionals, such as nurses and doctors, as they allow for the direct delivery of fluids, medications, blood products, and other treatments into the patient's circulatory system. These catheters come in various sizes and types, depending on the patient's age, medical condition, and the intended purpose of the IV therapy.  

Rise in prevalence of chronic diseases such as diabetes, cardiovascular conditions, cancer, and autoimmune disorders, has created a growing demand for long-term treatment and management. This involves the administration of medications, fluids, and nutrients directly into the bloodstream through intravenous (IV) therapy, which drives the demand for IV catheters.   

In addition, technological advancements in IV catheter designs and materials, as well as improved insertion techniques, have made these devices more efficient, comfortable, and safe. These innovations encourage healthcare providers to use IV catheters for a broader range of treatments and is one of the major IV catheters market trends.

For instance, Becton, Dickson and Company’s BD Insyte autoguard BC shield IV Catheter provides innovative intravenous catheter designs that ensure patient safety and convenience. In addition, this product has a push button needle shielding technology that instantly retracts the needle, completely encasing it in the safety barrel, and helping to reduce the risk of accidental needlestick injuries. Such advanced features provided by the IV catheters drive the market growth.  

Furthermore, surgical procedures, whether in hospitals or outpatient settings, often involve the use of IV catheters to administer anesthesia, pain relief, and other necessary medications. The growth in surgical procedures globally contributes to the demand for IV catheters and boosts the IV catheters market size.   

The IV catheters market is classified into product, type, end user, and region. By product, the market is classified into 18G, 20G, 22G, 24G, and others. The 22G segment dominated the market share in 2022, owing to the widespread adoption of 22G gauze size IV catheters, its versatility, patient comfort, and reduced patient discomfort during insertion. However, the 24G segment is expected to register the highest CAGR during the forecast period. This is attributed to rise in advancements in catheter technology that have made it possible for smaller-gauge catheters such as the 24G to accommodate a wide range of therapies.   

Depending on type, the market is classified into peripheral IV catheters, central venous catheters, and others. The peripheral IV catheters segment held the largest IV catheters market share in 2022. This is attributed to its ease of use, high safety profile, and suitability for short-term treatments. These advantages make peripheral IV catheters the preferred choice in a wide range of medical scenarios, contributing to their significant market share. 

However, the central venous catheters segment is expected to register the highest CAGR during the IV catheters market forecast period. This is attributed to the suitability of central venous catheters for long-term and specialized therapies, their role in critical care settings, rise in technological advancements, and increase in demand for extended intravenous access in various healthcare settings, which drives the demand for central venous catheters.  

Depending on the end user, the market is classified into hospitals, ambulatory surgical centers, and others. The hospitals segment dominated the IV catheters market share in 2022 and is expected to register the highest CAGR during the forecast period. This is attributed to the wide array of medical services, treatments provided by hospitals, their focus on patient care and safety, and rise in the number of surgical procedures performed in hospitals. In addition, hospitals have the infrastructure, staff, and resources to handle complex cases and advanced medical procedures that may involve specialized intravenous equipment, which further supports the segment growth.  

Region-wise, IV catheters market analysis is carries out accross North America, Europe, Asia-Pacific and LAMEA. North America was the largest shareholder in the market in 2022, owing to its well-developed healthcare infrastructure, rise in disease prevalence, robust reimbursement policies, presence of key market players, and availability of advanced products. In addition, this region has advanced medical facilities, including hospitals, clinics, and ambulatory surgical centers, which foster the demand for intravenous equipment, while the prevalence of chronic diseases and aging population contribute to the need for advanced medical treatments. 

However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period, owing to rapidly growing population, coupled with increase in prevalence of chronic diseases, which creates a significant demand for intravenous therapy and IV catheters. The upsurge in healthcare expenditure in the emerging economies is anticipated to offer lucrative opportunities for market expansion. 

Key Findings of the Study  

• By product, the 22G segment was the largest contributor to the IV catheters industry in 2022.    

• By type, the peripheral IV catheters segment dominated the market in 2022.   

• By end user, the hospitals segment dominated the market in 2022 and is expected to grow at a highest CAGR during the forecast period.   

• Region-wise, North America generated the largest revenue in 2022 in the IV catheters industry. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.